Mediguide-Assisted Transseptal Puncture without Echocardiographic Guidance

Area of Science:

• Cardiology
• Medical Devices
• Minimally Invasive Procedures

Background:

• Transseptal puncture (TSP) is crucial for catheter ablation procedures.
• Traditional TSP relies heavily on fluoroscopy, leading to significant radiation exposure for patients and staff.
• Minimizing radiation while maintaining procedural safety is a key challenge in electrophysiology.

Purpose of the Study:

• To describe and evaluate a novel nonfluoroscopic technique for left atrium transseptal puncture (TSP) using the MediGuide™ (MG) tracking system.
• To assess the feasibility, safety, and efficacy of MG-assisted TSP in reducing radiation exposure during atrial fibrillation ablation.
• To compare the outcomes of MG-assisted TSP with conventional fluoroscopically guided TSP.

Main Methods:

• A prospective study involving 31 consecutive patients undergoing MG-assisted percutaneous catheter ablation.
• Utilized the MediGuide™ system for nonfluoroscopic guidance of transseptal needle and guidewire advancement.
• A control group of 31 matched patients undergoing conventional fluoroscopically guided TSP was included for comparison.
• Left atrium access was confirmed by pressure changes and guidewire advancement.

Main Results:

• Sixty-two MG-assisted TSP attempts were performed with a 96.7% success rate, without conversion to conventional techniques.
• Mean total fluoroscopy time was significantly lower in the MG group (26.65 ± 37.97 seconds) compared to the conventional TSP group (129.13 ± 37.77 seconds) (P < 0.001).
• No major complications were observed in either group during the TSP procedure.

Conclusions:

• The MediGuide™ (MG) system enables a feasible and safe technique for transseptal puncture (TSP) with minimal radiation exposure.
• This nonfluoroscopic approach eliminates the need for additional imaging modalities like intracardiac echocardiography.
• MG-assisted TSP significantly reduces fluoroscopy time, offering a safer alternative for atrial fibrillation ablation procedures.